RetinalGenix Technologies (RTGN) Non Operating Interest Expenses (2021 - 2026)

RetinalGenix Technologies has disclosed Non Operating Interest Expenses across 6 years of filings, most recently posting $3955.0 for Q2 2026.

• In Q2 2026, Non Operating Interest Expenses rose 269.63% year-over-year to $3955.0; the TTM figure through Jun 2026 stood at $7241.0 (up 85.71% YoY), while the FY2025 annual figure was $4005.0, up 4.3% from the prior year.
• Non Operating Interest Expenses came in at $3955.0 for Q2 2026 at RetinalGenix Technologies, up from $1260.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $3955.0 in Q2 2026 to a low of $909.0 in Q1 2025.
• Average Non Operating Interest Expenses over 5 years is $1224.5, with a median of $960.0 recorded in 2022.
• Year-over-year, Non Operating Interest Expenses plunged 97.72% in 2022 and jumped 269.63% in 2026.
• Over 5 years, Non Operating Interest Expenses stood at $960.0 in 2022, then changed by 0.0% to $960.0 in 2023, then changed by 0.0% to $960.0 in 2024, then increased by 11.25% to $1068.0 in 2025, then surged by 270.32% to $3955.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $3955.0 in Q2 2026, $1260.0 in Q1 2026, and $1068.0 in Q4 2025.